

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | protein neddylation (GO:0045116) | 7.04967207 |
| 2 | regulation of platelet aggregation (GO:0090330) | 6.22155897 |
| 3 | ribosomal small subunit assembly (GO:0000028) | 6.09874323 |
| 4 | leukocyte migration involved in inflammatory response (GO:0002523) | 5.92489456 |
| 5 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.77044551 |
| 6 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 5.59805624 |
| 7 | blood coagulation, intrinsic pathway (GO:0007597) | 5.49999006 |
| 8 | adenosine receptor signaling pathway (GO:0001973) | 5.35601983 |
| 9 | positive regulation of B cell differentiation (GO:0045579) | 5.35457694 |
| 10 | platelet dense granule organization (GO:0060155) | 5.28595982 |
| 11 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.12410306 |
| 12 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 5.08952128 |
| 13 | negative regulation of thymocyte apoptotic process (GO:0070244) | 5.01053068 |
| 14 | positive regulation of mast cell activation (GO:0033005) | 4.91632783 |
| 15 | regulation of integrin-mediated signaling pathway (GO:2001044) | 4.89549109 |
| 16 | lipoxygenase pathway (GO:0019372) | 4.81783358 |
| 17 | definitive hemopoiesis (GO:0060216) | 4.78528006 |
| 18 | neutrophil activation (GO:0042119) | 4.75495525 |
| 19 | positive regulation of endothelial cell differentiation (GO:0045603) | 4.62964553 |
| 20 | mature B cell differentiation involved in immune response (GO:0002313) | 4.62009643 |
| 21 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.61815929 |
| 22 | megakaryocyte development (GO:0035855) | 4.59656833 |
| 23 | negative regulation of norepinephrine secretion (GO:0010700) | 4.57991078 |
| 24 | angiogenesis involved in wound healing (GO:0060055) | 4.57303990 |
| 25 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 4.47354368 |
| 26 | thrombin receptor signaling pathway (GO:0070493) | 4.46986511 |
| 27 | negative regulation of heart rate (GO:0010459) | 4.39139672 |
| 28 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 4.30610565 |
| 29 | maturation of SSU-rRNA (GO:0030490) | 4.28313949 |
| 30 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.25039252 |
| 31 | mature B cell differentiation (GO:0002335) | 4.22079588 |
| 32 | granulocyte activation (GO:0036230) | 4.20372864 |
| 33 | platelet degranulation (GO:0002576) | 4.18451938 |
| 34 | low-density lipoprotein particle remodeling (GO:0034374) | 4.07543805 |
| 35 | mast cell activation (GO:0045576) | 4.06314701 |
| 36 | regulation of gamma-delta T cell activation (GO:0046643) | 4.00754022 |
| 37 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 4.00037358 |
| 38 | viral transcription (GO:0019083) | 3.98135677 |
| 39 | positive regulation of cAMP-mediated signaling (GO:0043950) | 3.86040007 |
| 40 | histamine transport (GO:0051608) | 3.84363190 |
| 41 | polyamine biosynthetic process (GO:0006596) | 3.83945109 |
| 42 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.79743827 |
| 43 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.78949503 |
| 44 | regulation of homotypic cell-cell adhesion (GO:0034110) | 3.77903153 |
| 45 | regulation of lipoprotein metabolic process (GO:0050746) | 3.77496401 |
| 46 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.77305455 |
| 47 | Peyers patch development (GO:0048541) | 3.77305455 |
| 48 | platelet aggregation (GO:0070527) | 3.70544630 |
| 49 | platelet formation (GO:0030220) | 3.70244880 |
| 50 | regulation of MHC class II biosynthetic process (GO:0045346) | 3.69130147 |
| 51 | secretory granule organization (GO:0033363) | 3.67560742 |
| 52 | negative regulation of protein localization to cell surface (GO:2000009) | 3.62695939 |
| 53 | fusion of sperm to egg plasma membrane (GO:0007342) | 3.62676188 |
| 54 | positive regulation of Rho protein signal transduction (GO:0035025) | 3.61273322 |
| 55 | translational termination (GO:0006415) | 3.59862510 |
| 56 | negative regulation of response to food (GO:0032096) | 3.59180018 |
| 57 | negative regulation of appetite (GO:0032099) | 3.59180018 |
| 58 | positive regulation of receptor recycling (GO:0001921) | 3.59078202 |
| 59 | negative regulation of bone mineralization (GO:0030502) | 3.57916699 |
| 60 | * platelet activation (GO:0030168) | 3.57757725 |
| 61 | germinal center formation (GO:0002467) | 3.56977695 |
| 62 | regulation of erythrocyte differentiation (GO:0045646) | 3.55905954 |
| 63 | negative regulation of hematopoietic progenitor cell differentiation (GO:1901533) | 3.54569202 |
| 64 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 3.53761634 |
| 65 | purinergic receptor signaling pathway (GO:0035587) | 3.52588059 |
| 66 | T cell homeostasis (GO:0043029) | 3.50629926 |
| 67 | ribosomal small subunit biogenesis (GO:0042274) | 3.49263964 |
| 68 | positive regulation of hemostasis (GO:1900048) | 3.49113621 |
| 69 | positive regulation of blood coagulation (GO:0030194) | 3.49113621 |
| 70 | positive regulation of systemic arterial blood pressure (GO:0003084) | 3.48708162 |
| 71 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 3.47971664 |
| 72 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 3.45946989 |
| 73 | negative regulation of T cell apoptotic process (GO:0070233) | 3.37983179 |
| 74 | immunoglobulin mediated immune response (GO:0016064) | 3.35220349 |
| 75 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.34313329 |
| 76 | beta-amyloid metabolic process (GO:0050435) | 3.32388140 |
| 77 | regulation of mast cell activation (GO:0033003) | 3.32182187 |
| 78 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.31628431 |
| 79 | negative regulation of platelet activation (GO:0010544) | 3.29668791 |
| 80 | leukocyte degranulation (GO:0043299) | 3.29506281 |
| 81 | negative regulation of neural precursor cell proliferation (GO:2000178) | 3.29461351 |
| 82 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.29436995 |
| 83 | extracellular fibril organization (GO:0043206) | 3.27105923 |
| 84 | positive regulation of mast cell degranulation (GO:0043306) | 3.26612504 |
| 85 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.26612504 |
| 86 | regulation of platelet activation (GO:0010543) | 3.26396800 |
| 87 | histamine secretion (GO:0001821) | 3.26231515 |
| 88 | translational elongation (GO:0006414) | 3.25814904 |
| 89 | regulation of mast cell degranulation (GO:0043304) | 3.24212849 |
| 90 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.23486316 |
| 91 | negative regulation of heart contraction (GO:0045822) | 3.21944061 |
| 92 | regulation of B cell differentiation (GO:0045577) | 3.19541452 |
| 93 | termination of G-protein coupled receptor signaling pathway (GO:0038032) | 3.19384907 |
| 94 | termination of signal transduction (GO:0023021) | 3.18378177 |
| 95 | B cell activation involved in immune response (GO:0002312) | 3.16660382 |
| 96 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.15145316 |
| 97 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.14004767 |
| 98 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.14004767 |
| 99 | positive regulation of coagulation (GO:0050820) | 3.13372192 |
| 100 | myeloid dendritic cell activation (GO:0001773) | 3.12704280 |
| 101 | autophagic vacuole fusion (GO:0000046) | 3.11434797 |
| 102 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.10101895 |
| 103 | regulation of norepinephrine secretion (GO:0014061) | 3.09657118 |
| 104 | phagocytosis, engulfment (GO:0006911) | 3.07462194 |
| 105 | response to muramyl dipeptide (GO:0032495) | 3.06863511 |
| 106 | endosome to pigment granule transport (GO:0043485) | 3.06778955 |
| 107 | endosome to melanosome transport (GO:0035646) | 3.06778955 |
| 108 | regulation of endothelial cell differentiation (GO:0045601) | 3.06347028 |
| 109 | long-chain fatty acid biosynthetic process (GO:0042759) | 3.06321144 |
| 110 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.05639622 |
| 111 | mast cell activation involved in immune response (GO:0002279) | 3.05558607 |
| 112 | mast cell degranulation (GO:0043303) | 3.05558607 |
| 113 | neutrophil activation involved in immune response (GO:0002283) | 3.05546034 |
| 114 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.05514033 |
| 115 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.04485702 |
| 116 | positive regulation of macrophage differentiation (GO:0045651) | 3.03146242 |
| 117 | mitochondrial calcium ion transport (GO:0006851) | 3.02499169 |
| 118 | regulation of cholesterol efflux (GO:0010874) | 3.00662327 |
| 119 | negative regulation of biomineral tissue development (GO:0070168) | 2.99667738 |
| 120 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.99562409 |
| 121 | purine nucleotide salvage (GO:0032261) | 2.97783843 |
| 122 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.97447423 |
| 123 | response to interferon-beta (GO:0035456) | 2.97213970 |
| 124 | regulation of integrin activation (GO:0033623) | 2.96771711 |
| 125 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 2.95839529 |
| 126 | negative regulation of stress fiber assembly (GO:0051497) | 2.94999737 |
| 127 | protein targeting to ER (GO:0045047) | 2.94511599 |
| 128 | cotranslational protein targeting to membrane (GO:0006613) | 2.94437302 |
| 129 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.94016337 |
| 130 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 2.91919469 |
| 131 | regulation of regulatory T cell differentiation (GO:0045589) | 2.91898175 |
| 132 | pyrimidine nucleoside catabolic process (GO:0046135) | 2.91250910 |
| 133 | high-density lipoprotein particle remodeling (GO:0034375) | 2.89533831 |
| 134 | regulation of receptor recycling (GO:0001919) | 2.88711076 |
| 135 | phospholipid homeostasis (GO:0055091) | 2.87122594 |
| 136 | regulation of hemostasis (GO:1900046) | 2.86754332 |
| 137 | regulation of blood coagulation (GO:0030193) | 2.86754332 |
| 138 | vesicle targeting (GO:0006903) | 2.86065447 |
| 139 | viral life cycle (GO:0019058) | 2.85634438 |
| 140 | coenzyme A biosynthetic process (GO:0015937) | 2.85415958 |
| 141 | fibril organization (GO:0097435) | 2.85411945 |
| 142 | erythrocyte maturation (GO:0043249) | 2.85236686 |
| 143 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.83764839 |
| 144 | B cell mediated immunity (GO:0019724) | 2.83253699 |
| 145 | cyclooxygenase pathway (GO:0019371) | 2.83140570 |
| 146 | negative regulation of granulocyte differentiation (GO:0030853) | 2.82987735 |
| 147 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.79998817 |
| 148 | NIK/NF-kappaB signaling (GO:0038061) | 2.79998752 |
| 149 | myeloid cell development (GO:0061515) | 2.79893496 |
| 150 | myeloid cell activation involved in immune response (GO:0002275) | 2.79193376 |
| 151 | galactose catabolic process (GO:0019388) | 2.78967425 |
| 152 | negative regulation of catecholamine secretion (GO:0033604) | 2.78049466 |
| 153 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.77922094 |
| 154 | reverse cholesterol transport (GO:0043691) | 2.77733211 |
| 155 | positive regulation of granulocyte differentiation (GO:0030854) | 2.76845508 |
| 156 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.75716682 |
| 157 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.75356842 |
| 158 | positive regulation of B cell mediated immunity (GO:0002714) | 2.75356842 |
| 159 | positive regulation of antigen processing and presentation (GO:0002579) | 2.75044637 |
| 160 | superoxide anion generation (GO:0042554) | 2.74997558 |
| 161 | cellular biogenic amine biosynthetic process (GO:0042401) | 2.74872355 |
| 162 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.74512768 |
| 163 | negative regulation of histone methylation (GO:0031061) | 2.74445201 |
| 164 | cellular protein complex disassembly (GO:0043624) | 2.74408299 |
| 165 | protein localization to endoplasmic reticulum (GO:0070972) | 2.73583206 |
| 166 | DNA strand elongation (GO:0022616) | 2.73076530 |
| 167 | embryonic hemopoiesis (GO:0035162) | 2.71746144 |
| 168 | phospholipid scrambling (GO:0017121) | 2.68884607 |
| 169 | programmed necrotic cell death (GO:0097300) | 2.68295480 |
| 170 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.68240089 |
| 171 | intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631) | 2.67771430 |
| 172 | regulation of necroptotic process (GO:0060544) | 2.67696389 |
| 173 | defense response to protozoan (GO:0042832) | 2.67585938 |
| 174 | regulation of macrophage differentiation (GO:0045649) | 2.67365255 |
| 175 | protein kinase C signaling (GO:0070528) | 2.63825169 |
| 176 | opsonization (GO:0008228) | 2.63624305 |
| 177 | natural killer cell activation involved in immune response (GO:0002323) | 2.61732420 |
| 178 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.61460074 |
| 179 | somatic recombination of immunoglobulin genes involved in immune response (GO:0002204) | 2.61180529 |
| 180 | somatic diversification of immunoglobulins involved in immune response (GO:0002208) | 2.61180529 |
| 181 | isotype switching (GO:0045190) | 2.61180529 |
| 182 | dendritic cell differentiation (GO:0097028) | 2.60869776 |
| 183 | homotypic cell-cell adhesion (GO:0034109) | 2.60518485 |
| 184 | lymphocyte homeostasis (GO:0002260) | 2.60108634 |
| 185 | positive regulation of erythrocyte differentiation (GO:0045648) | 2.59396126 |
| 186 | B cell receptor signaling pathway (GO:0050853) | 2.58857638 |
| 187 | negative regulation of interleukin-8 production (GO:0032717) | 2.58782115 |
| 188 | DNA topological change (GO:0006265) | 2.57408624 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SCL_19346495_ChIP-Seq_HPC-7_Human | 6.37898377 |
| 2 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.29503538 |
| 3 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 4.36437091 |
| 4 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 3.23384979 |
| 5 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.15799032 |
| 6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.14099291 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.03043877 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.95788908 |
| 9 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.86415810 |
| 10 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.85478754 |
| 11 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.81275815 |
| 12 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.81086530 |
| 13 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.79044774 |
| 14 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.51786457 |
| 15 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.50391426 |
| 16 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.49981476 |
| 17 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.42214510 |
| 18 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 2.40706266 |
| 19 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.36337040 |
| 20 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 2.29089744 |
| 21 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.28303842 |
| 22 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 2.25356588 |
| 23 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 2.21563033 |
| 24 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.18887008 |
| 25 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 2.17821539 |
| 26 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.10069895 |
| 27 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.08146670 |
| 28 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.05123119 |
| 29 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 2.04792131 |
| 30 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.98164559 |
| 31 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.97154439 |
| 32 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.96207926 |
| 33 | GATA1_19941826_ChIP-Seq_K562_Human | 1.94517674 |
| 34 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.94101091 |
| 35 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.90842301 |
| 36 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.90708632 |
| 37 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.88521521 |
| 38 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.83691891 |
| 39 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.81697310 |
| 40 | UTX_26944678_Chip-Seq_JUKART_Human | 1.79908744 |
| 41 | MYC_22102868_ChIP-Seq_BL_Human | 1.77343386 |
| 42 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.77246943 |
| 43 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.77111536 |
| 44 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.76535530 |
| 45 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.76122341 |
| 46 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.74767163 |
| 47 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.73484918 |
| 48 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.71998559 |
| 49 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.70989615 |
| 50 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.69658657 |
| 51 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.68638867 |
| 52 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.68581987 |
| 53 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.68123288 |
| 54 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.64351846 |
| 55 | MAF_26560356_Chip-Seq_TH1_Human | 1.64291651 |
| 56 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.63831235 |
| 57 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.58830795 |
| 58 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 1.58535640 |
| 59 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.56839556 |
| 60 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.52704630 |
| 61 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.52066072 |
| 62 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.51477383 |
| 63 | MYB_26560356_Chip-Seq_TH1_Human | 1.49372886 |
| 64 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.45925289 |
| 65 | SPI1_23127762_ChIP-Seq_K562_Human | 1.45598408 |
| 66 | MYB_26560356_Chip-Seq_TH2_Human | 1.39420026 |
| 67 | GATA1_22025678_ChIP-Seq_K562_Human | 1.38790417 |
| 68 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.33969503 |
| 69 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.30254444 |
| 70 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.28702540 |
| 71 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.28490817 |
| 72 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.27502515 |
| 73 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.25831048 |
| 74 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.24328698 |
| 75 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.23605233 |
| 76 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.23543346 |
| 77 | GATA2_19941826_ChIP-Seq_K562_Human | 1.22352687 |
| 78 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.22336307 |
| 79 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.22271033 |
| 80 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.21559375 |
| 81 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.21375185 |
| 82 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.20382170 |
| 83 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.19355578 |
| 84 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.18792675 |
| 85 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.18274369 |
| 86 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.17718438 |
| 87 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.17557763 |
| 88 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.12245875 |
| 89 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.11738458 |
| 90 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.11738458 |
| 91 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.11308086 |
| 92 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.11107374 |
| 93 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.09250732 |
| 94 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.08336506 |
| 95 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.07702979 |
| 96 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.07620909 |
| 97 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.07468548 |
| 98 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.07248166 |
| 99 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.06603723 |
| 100 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.05512540 |
| 101 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.05447073 |
| 102 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.02115825 |
| 103 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.01594543 |
| 104 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.01454962 |
| 105 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.00013124 |
| 106 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.96517827 |
| 107 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.95694126 |
| 108 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.95510876 |
| 109 | * ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.95492143 |
| 110 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.95476136 |
| 111 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.95249095 |
| 112 | MAF_26560356_Chip-Seq_TH2_Human | 0.94108398 |
| 113 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.93958870 |
| 114 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.93762530 |
| 115 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.92962206 |
| 116 | P300_27268052_Chip-Seq_Bcells_Human | 0.91866062 |
| 117 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.91334407 |
| 118 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.89490993 |
| 119 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89297134 |
| 120 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.87712695 |
| 121 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.87705586 |
| 122 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.87418821 |
| 123 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.87011573 |
| 124 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.86807873 |
| 125 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.86278077 |
| 126 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.85009119 |
| 127 | LMO2_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.84498799 |
| 128 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.80573137 |
| 129 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.80154206 |
| 130 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.80136850 |
| 131 | * GATA3_26560356_Chip-Seq_TH2_Human | 0.80129253 |
| 132 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.79982588 |
| 133 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.79808458 |
| 134 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.79092789 |
| 135 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.78683602 |
| 136 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.78473452 |
| 137 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.78258250 |
| 138 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.77884774 |
| 139 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.77574872 |
| 140 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.74961405 |
| 141 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.74845039 |
| 142 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.74344841 |
| 143 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.73947728 |
| 144 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.73885710 |
| 145 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.73661120 |
| 146 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.72776399 |
| 147 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.72725765 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * MP0005464_abnormal_platelet_physiology | 4.43003938 |
| 2 | MP0002396_abnormal_hematopoietic_system | 3.68628070 |
| 3 | MP0000465_gastrointestinal_hemorrhage | 3.54158907 |
| 4 | MP0006054_spinal_hemorrhage | 3.33160851 |
| 5 | MP0004808_abnormal_hematopoietic_stem | 3.26611032 |
| 6 | MP0001545_abnormal_hematopoietic_system | 3.15635646 |
| 7 | MP0005397_hematopoietic_system_phenotyp | 3.15635646 |
| 8 | MP0000685_abnormal_immune_system | 3.13727991 |
| 9 | MP0005671_abnormal_response_to | 3.12030292 |
| 10 | MP0003724_increased_susceptibility_to | 2.81747049 |
| 11 | MP0004510_myositis | 2.77754387 |
| 12 | MP0001835_abnormal_antigen_presentation | 2.59436143 |
| 13 | MP0005083_abnormal_biliary_tract | 2.43153707 |
| 14 | MP0004147_increased_porphyrin_level | 2.38081153 |
| 15 | MP0009278_abnormal_bone_marrow | 2.35893247 |
| 16 | MP0003303_peritoneal_inflammation | 2.11095782 |
| 17 | MP0001800_abnormal_humoral_immune | 2.00774918 |
| 18 | MP0002419_abnormal_innate_immunity | 1.94067046 |
| 19 | MP0000230_abnormal_systemic_arterial | 1.93991863 |
| 20 | * MP0002398_abnormal_bone_marrow | 1.93436560 |
| 21 | MP0003567_abnormal_fetal_cardiomyocyte | 1.92907854 |
| 22 | MP0002736_abnormal_nociception_after | 1.89945850 |
| 23 | MP0002148_abnormal_hypersensitivity_rea | 1.89783331 |
| 24 | MP0004084_abnormal_cardiac_muscle | 1.89382485 |
| 25 | MP0005000_abnormal_immune_tolerance | 1.86805861 |
| 26 | MP0000689_abnormal_spleen_morphology | 1.85416577 |
| 27 | MP0003436_decreased_susceptibility_to | 1.85174290 |
| 28 | MP0005025_abnormal_response_to | 1.81359678 |
| 29 | MP0008057_abnormal_DNA_replication | 1.80390407 |
| 30 | MP0003763_abnormal_thymus_physiology | 1.80234732 |
| 31 | MP0002452_abnormal_antigen_presenting | 1.79574452 |
| 32 | MP0002722_abnormal_immune_system | 1.79100898 |
| 33 | * MP0002723_abnormal_immune_serum | 1.77376314 |
| 34 | MP0003638_abnormal_response/metabolism_ | 1.72734801 |
| 35 | MP0003656_abnormal_erythrocyte_physiolo | 1.72727511 |
| 36 | MP0002420_abnormal_adaptive_immunity | 1.70968471 |
| 37 | MP0001853_heart_inflammation | 1.68891513 |
| 38 | MP0001819_abnormal_immune_cell | 1.67836888 |
| 39 | MP0005084_abnormal_gallbladder_morpholo | 1.67286415 |
| 40 | MP0002405_respiratory_system_inflammati | 1.67081100 |
| 41 | MP0000343_altered_response_to | 1.62878695 |
| 42 | MP0009785_altered_susceptibility_to | 1.62735811 |
| 43 | MP0001879_abnormal_lymphatic_vessel | 1.59758430 |
| 44 | MP0005174_abnormal_tail_pigmentation | 1.58649159 |
| 45 | MP0003879_abnormal_hair_cell | 1.54979126 |
| 46 | MP0010155_abnormal_intestine_physiology | 1.52267100 |
| 47 | MP0000490_abnormal_crypts_of | 1.48158686 |
| 48 | * MP0002429_abnormal_blood_cell | 1.47883966 |
| 49 | MP0002638_abnormal_pupillary_reflex | 1.47406515 |
| 50 | MP0005410_abnormal_fertilization | 1.46875200 |
| 51 | MP0005075_abnormal_melanosome_morpholog | 1.44611191 |
| 52 | MP0000716_abnormal_immune_system | 1.44335516 |
| 53 | MP0009333_abnormal_splenocyte_physiolog | 1.42692553 |
| 54 | MP0001873_stomach_inflammation | 1.42664329 |
| 55 | MP0008872_abnormal_physiological_respon | 1.42487947 |
| 56 | MP0004036_abnormal_muscle_relaxation | 1.37996046 |
| 57 | MP0009764_decreased_sensitivity_to | 1.32517478 |
| 58 | MP0003566_abnormal_cell_adhesion | 1.32409438 |
| 59 | MP0003300_gastrointestinal_ulcer | 1.31497846 |
| 60 | MP0009379_abnormal_foot_pigmentation | 1.30939563 |
| 61 | MP0008004_abnormal_stomach_pH | 1.30411986 |
| 62 | MP0005387_immune_system_phenotype | 1.29459139 |
| 63 | MP0001790_abnormal_immune_system | 1.29459139 |
| 64 | MP0003866_abnormal_defecation | 1.27133072 |
| 65 | MP0006082_CNS_inflammation | 1.25493382 |
| 66 | MP0003828_pulmonary_edema | 1.25351912 |
| 67 | MP0005647_abnormal_sex_gland | 1.23622838 |
| 68 | MP0005167_abnormal_blood-brain_barrier | 1.23385987 |
| 69 | MP0008469_abnormal_protein_level | 1.21738075 |
| 70 | MP0010094_abnormal_chromosome_stability | 1.21583052 |
| 71 | MP0003172_abnormal_lysosome_physiology | 1.20490948 |
| 72 | MP0001968_abnormal_touch/_nociception | 1.18749947 |
| 73 | * MP0001845_abnormal_inflammatory_respons | 1.16481567 |
| 74 | MP0000703_abnormal_thymus_morphology | 1.16191645 |
| 75 | MP0004947_skin_inflammation | 1.15795292 |
| 76 | MP0003191_abnormal_cellular_cholesterol | 1.15006964 |
| 77 | MP0002733_abnormal_thermal_nociception | 1.11562733 |
| 78 | MP0004264_abnormal_extraembryonic_tissu | 1.11523850 |
| 79 | MP0010368_abnormal_lymphatic_system | 1.08351472 |
| 80 | MP0003111_abnormal_nucleus_morphology | 1.05921884 |
| 81 | MP0003075_altered_response_to | 1.04736627 |
| 82 | MP0005409_darkened_coat_color | 1.03816420 |
| 83 | MP0002095_abnormal_skin_pigmentation | 1.02936051 |
| 84 | MP0005646_abnormal_pituitary_gland | 1.02917293 |
| 85 | MP0001663_abnormal_digestive_system | 1.02705397 |
| 86 | MP0002998_abnormal_bone_remodeling | 1.00826982 |
| 87 | MP0003279_aneurysm | 0.96225762 |
| 88 | MP0002166_altered_tumor_susceptibility | 0.93283849 |
| 89 | MP0003077_abnormal_cell_cycle | 0.93189080 |
| 90 | MP0009763_increased_sensitivity_to | 0.89658581 |
| 91 | MP0001533_abnormal_skeleton_physiology | 0.89187255 |
| 92 | MP0000767_abnormal_smooth_muscle | 0.88970160 |
| 93 | MP0000015_abnormal_ear_pigmentation | 0.88901429 |
| 94 | MP0005381_digestive/alimentary_phenotyp | 0.88424716 |
| 95 | MP0003943_abnormal_hepatobiliary_system | 0.88231024 |
| 96 | * MP0009642_abnormal_blood_homeostasis | 0.88151412 |
| 97 | MP0009765_abnormal_xenobiotic_induced | 0.88005021 |
| 98 | MP0002089_abnormal_postnatal_growth/wei | 0.87914970 |
| 99 | MP0002876_abnormal_thyroid_physiology | 0.86930271 |
| 100 | MP0000313_abnormal_cell_death | 0.86504850 |
| 101 | MP0001191_abnormal_skin_condition | 0.84296971 |
| 102 | MP0005165_increased_susceptibility_to | 0.83425950 |
| 103 | MP0005023_abnormal_wound_healing | 0.83081513 |
| 104 | MP0003448_altered_tumor_morphology | 0.82475377 |
| 105 | MP0001851_eye_inflammation | 0.79587070 |
| 106 | MP0000249_abnormal_blood_vessel | 0.79357756 |
| 107 | MP0005058_abnormal_lysosome_morphology | 0.79219097 |
| 108 | MP0001765_abnormal_ion_homeostasis | 0.78395709 |
| 109 | MP0001970_abnormal_pain_threshold | 0.76497855 |
| 110 | MP0002006_tumorigenesis | 0.76216746 |
| 111 | MP0004215_abnormal_myocardial_fiber | 0.75190756 |
| 112 | MP0008260_abnormal_autophagy | 0.75178471 |
| 113 | MP0010329_abnormal_lipoprotein_level | 0.74632070 |
| 114 | MP0003453_abnormal_keratinocyte_physiol | 0.73618812 |
| 115 | MP0008775_abnormal_heart_ventricle | 0.73590764 |
| 116 | MP0001664_abnormal_digestion | 0.73274248 |
| 117 | MP0002877_abnormal_melanocyte_morpholog | 0.72468976 |
| 118 | MP0004883_abnormal_blood_vessel | 0.72066949 |
| 119 | MP0002019_abnormal_tumor_incidence | 0.71549445 |
| 120 | MP0005360_urolithiasis | 0.70785310 |
| 121 | MP0002972_abnormal_cardiac_muscle | 0.70744547 |
| 122 | MP0000858_altered_metastatic_potential | 0.69823860 |
| 123 | MP0010352_gastrointestinal_tract_polyps | 0.69802156 |
| 124 | MP0008058_abnormal_DNA_repair | 0.69794621 |
| 125 | MP0003183_abnormal_peptide_metabolism | 0.69453388 |
| 126 | MP0004484_altered_response_of | 0.68595228 |
| 127 | MP0002132_abnormal_respiratory_system | 0.68538064 |
| 128 | MP0005535_abnormal_body_temperature | 0.68296884 |
| 129 | MP0003011_delayed_dark_adaptation | 0.67377908 |
| 130 | MP0005385_cardiovascular_system_phenoty | 0.67266966 |
| 131 | MP0001544_abnormal_cardiovascular_syste | 0.67266966 |
| 132 | MP0002118_abnormal_lipid_homeostasis | 0.66252042 |
| 133 | MP0004130_abnormal_muscle_cell | 0.66235263 |
| 134 | MP0008874_decreased_physiological_sensi | 0.64930736 |
| 135 | MP0006138_congestive_heart_failure | 0.63838611 |
| 136 | MP0005666_abnormal_adipose_tissue | 0.62761276 |
| 137 | MP0005501_abnormal_skin_physiology | 0.61496639 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Prolonged bleeding time (HP:0003010) | 7.27426100 |
| 2 | Petechiae (HP:0000967) | 6.97074525 |
| 3 | Increased mean platelet volume (HP:0011877) | 6.47852269 |
| 4 | Purpura (HP:0000979) | 6.28423685 |
| 5 | Abnormal platelet volume (HP:0011876) | 6.25770026 |
| 6 | Hyperlipoproteinemia (HP:0010980) | 5.94746575 |
| 7 | Menorrhagia (HP:0000132) | 5.89080290 |
| 8 | Epistaxis (HP:0000421) | 4.99929108 |
| 9 | Gingival bleeding (HP:0000225) | 4.81057265 |
| 10 | Acanthocytosis (HP:0001927) | 4.80048692 |
| 11 | Spontaneous hematomas (HP:0007420) | 4.67339156 |
| 12 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 4.40602679 |
| 13 | Abnormal platelet function (HP:0011869) | 4.28847162 |
| 14 | Impaired platelet aggregation (HP:0003540) | 4.28847162 |
| 15 | Recurrent abscess formation (HP:0002722) | 4.00461562 |
| 16 | Poikilocytosis (HP:0004447) | 3.98735744 |
| 17 | Recurrent bacterial skin infections (HP:0005406) | 3.80655489 |
| 18 | Thrombocytosis (HP:0001894) | 3.72007606 |
| 19 | Conjunctival telangiectasia (HP:0000524) | 3.68234329 |
| 20 | Abnormal number of erythroid precursors (HP:0012131) | 3.53308815 |
| 21 | Hypobetalipoproteinemia (HP:0003563) | 3.50523560 |
| 22 | Dyschromatopsia (HP:0007641) | 3.49727317 |
| 23 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.30775863 |
| 24 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 3.28218842 |
| 25 | Abnormal pupillary function (HP:0007686) | 3.23573148 |
| 26 | Increased density of long bones (HP:0006392) | 3.13714445 |
| 27 | Reticulocytopenia (HP:0001896) | 3.13046548 |
| 28 | Interstitial pulmonary disease (HP:0006530) | 3.10397375 |
| 29 | Dry hair (HP:0011359) | 3.10117265 |
| 30 | Aplastic anemia (HP:0001915) | 3.08912246 |
| 31 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.03918029 |
| 32 | Paralysis (HP:0003470) | 2.98394337 |
| 33 | Recurrent viral infections (HP:0004429) | 2.97221683 |
| 34 | Colitis (HP:0002583) | 2.90846939 |
| 35 | Cellulitis (HP:0100658) | 2.89169199 |
| 36 | Stomatitis (HP:0010280) | 2.82326586 |
| 37 | Hepatosplenomegaly (HP:0001433) | 2.81901866 |
| 38 | Abnormality of macrophages (HP:0004311) | 2.58743840 |
| 39 | Anhidrosis (HP:0000970) | 2.56696036 |
| 40 | Amaurosis fugax (HP:0100576) | 2.56126630 |
| 41 | Increased IgM level (HP:0003496) | 2.52627805 |
| 42 | Increased serum ferritin (HP:0003281) | 2.51722706 |
| 43 | Joint hemorrhage (HP:0005261) | 2.45936253 |
| 44 | Poikiloderma (HP:0001029) | 2.45547172 |
| 45 | Joint swelling (HP:0001386) | 2.44705635 |
| 46 | Inflammation of the large intestine (HP:0002037) | 2.42152478 |
| 47 | Increased hepatocellular lipid droplets (HP:0006565) | 2.42143341 |
| 48 | Panhypogammaglobulinemia (HP:0003139) | 2.41944821 |
| 49 | Xanthomatosis (HP:0000991) | 2.40622439 |
| 50 | Hypoplasia of the thymus (HP:0000778) | 2.39198825 |
| 51 | Nonimmune hydrops fetalis (HP:0001790) | 2.36818185 |
| 52 | Recurrent skin infections (HP:0001581) | 2.35151571 |
| 53 | IgM deficiency (HP:0002850) | 2.33613040 |
| 54 | Lipid accumulation in hepatocytes (HP:0006561) | 2.32779817 |
| 55 | Abnormality of reticulocytes (HP:0004312) | 2.31280664 |
| 56 | Gastrointestinal inflammation (HP:0004386) | 2.30986246 |
| 57 | Chronic obstructive pulmonary disease (HP:0006510) | 2.29549223 |
| 58 | Obstructive lung disease (HP:0006536) | 2.29549223 |
| 59 | Recurrent fungal infections (HP:0002841) | 2.28479063 |
| 60 | Myositis (HP:0100614) | 2.27706009 |
| 61 | Chronic otitis media (HP:0000389) | 2.25897800 |
| 62 | Akinesia (HP:0002304) | 2.25086908 |
| 63 | Agammaglobulinemia (HP:0004432) | 2.23128138 |
| 64 | Mediastinal lymphadenopathy (HP:0100721) | 2.22922760 |
| 65 | Agnosia (HP:0010524) | 2.22267825 |
| 66 | Pallor (HP:0000980) | 2.22105021 |
| 67 | Upper limb muscle weakness (HP:0003484) | 2.21791220 |
| 68 | Bruising susceptibility (HP:0000978) | 2.21676739 |
| 69 | Microvesicular hepatic steatosis (HP:0001414) | 2.20994995 |
| 70 | Exertional dyspnea (HP:0002875) | 2.20210360 |
| 71 | Global brain atrophy (HP:0002283) | 2.19573202 |
| 72 | Type 2 muscle fiber atrophy (HP:0003554) | 2.17652344 |
| 73 | Encephalitis (HP:0002383) | 2.16793064 |
| 74 | Increased IgE level (HP:0003212) | 2.14338705 |
| 75 | Entropion (HP:0000621) | 2.11889325 |
| 76 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.11587653 |
| 77 | Tinnitus (HP:0000360) | 2.10001781 |
| 78 | Dysphonia (HP:0001618) | 2.09389496 |
| 79 | Abnormality of the prostate (HP:0008775) | 2.08657180 |
| 80 | Episodic fever (HP:0001954) | 2.06312826 |
| 81 | Fatigue (HP:0012378) | 2.04031777 |
| 82 | Ventricular fibrillation (HP:0001663) | 2.03662076 |
| 83 | Thyroiditis (HP:0100646) | 2.03336923 |
| 84 | Myelodysplasia (HP:0002863) | 2.03106715 |
| 85 | Abnormality of lateral ventricle (HP:0030047) | 2.02592678 |
| 86 | Abnormality of iron homeostasis (HP:0011031) | 2.01169413 |
| 87 | Neurodegeneration (HP:0002180) | 2.00645738 |
| 88 | Arterial thrombosis (HP:0004420) | 2.00265220 |
| 89 | Eczematoid dermatitis (HP:0000976) | 1.99569629 |
| 90 | Papilledema (HP:0001085) | 1.98076140 |
| 91 | Nausea (HP:0002018) | 1.97258296 |
| 92 | Tongue fasciculations (HP:0001308) | 1.96264542 |
| 93 | Pancytopenia (HP:0001876) | 1.95750882 |
| 94 | Decreased central vision (HP:0007663) | 1.95706746 |
| 95 | Male infertility (HP:0003251) | 1.94827654 |
| 96 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.94141596 |
| 97 | Papillary thyroid carcinoma (HP:0002895) | 1.94036358 |
| 98 | Leukocytosis (HP:0001974) | 1.93905445 |
| 99 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.93731799 |
| 100 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.93731799 |
| 101 | Generalized aminoaciduria (HP:0002909) | 1.93578920 |
| 102 | Colon cancer (HP:0003003) | 1.90689898 |
| 103 | Muscle fiber atrophy (HP:0100295) | 1.88819240 |
| 104 | Vacuolated lymphocytes (HP:0001922) | 1.88643949 |
| 105 | Basal ganglia calcification (HP:0002135) | 1.88492337 |
| 106 | Reticulocytosis (HP:0001923) | 1.85287355 |
| 107 | Tetraparesis (HP:0002273) | 1.85279013 |
| 108 | Hyperthyroidism (HP:0000836) | 1.83551688 |
| 109 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.82661577 |
| 110 | Dysautonomia (HP:0002459) | 1.81876303 |
| 111 | Myocardial infarction (HP:0001658) | 1.81567018 |
| 112 | Periodontitis (HP:0000704) | 1.81433373 |
| 113 | Reduced antithrombin III activity (HP:0001976) | 1.79755525 |
| 114 | Urticaria (HP:0001025) | 1.78834590 |
| 115 | Asplenia (HP:0001746) | 1.77407225 |
| 116 | Gastrointestinal stroma tumor (HP:0100723) | 1.75923649 |
| 117 | Abnormality of the basal ganglia (HP:0002134) | 1.74915708 |
| 118 | Autoimmune thrombocytopenia (HP:0001973) | 1.72781967 |
| 119 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.71991558 |
| 120 | Muscle fibrillation (HP:0010546) | 1.71880820 |
| 121 | Sepsis (HP:0100806) | 1.71810883 |
| 122 | Abnormality of the common coagulation pathway (HP:0010990) | 1.71694914 |
| 123 | Increased intramyocellular lipid droplets (HP:0012240) | 1.70810261 |
| 124 | Dysostosis multiplex (HP:0000943) | 1.70724563 |
| 125 | Distal lower limb amyotrophy (HP:0008944) | 1.69489876 |
| 126 | Chest pain (HP:0100749) | 1.69079479 |
| 127 | Vertigo (HP:0002321) | 1.68778282 |
| 128 | Autoimmune hemolytic anemia (HP:0001890) | 1.68228470 |
| 129 | Thyroid-stimulating hormone excess (HP:0002925) | 1.67498374 |
| 130 | Spontaneous abortion (HP:0005268) | 1.66804939 |
| 131 | Ragged-red muscle fibers (HP:0003200) | 1.66764235 |
| 132 | Macrocytic anemia (HP:0001972) | 1.66508900 |
| 133 | Polycythemia (HP:0001901) | 1.66449810 |
| 134 | Recurrent bronchitis (HP:0002837) | 1.65592532 |
| 135 | Lymphoma (HP:0002665) | 1.65310498 |
| 136 | Abnormal auditory evoked potentials (HP:0006958) | 1.65058639 |
| 137 | Recurrent cutaneous fungal infections (HP:0011370) | 1.64541096 |
| 138 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.64541096 |
| 139 | Abnormality of binocular vision (HP:0011514) | 1.61347262 |
| 140 | Diplopia (HP:0000651) | 1.61347262 |
| 141 | Hypophosphatemic rickets (HP:0004912) | 1.59081629 |
| 142 | 3-Methylglutaconic aciduria (HP:0003535) | 1.55595907 |
| 143 | Abnormal ciliary motility (HP:0012262) | 1.55383730 |
| 144 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.54856569 |
| 145 | Uterine leiomyosarcoma (HP:0002891) | 1.54150466 |
| 146 | Leiomyosarcoma (HP:0100243) | 1.54150466 |
| 147 | Biliary tract neoplasm (HP:0100574) | 1.51834830 |
| 148 | Transitional cell carcinoma of the bladder (HP:0006740) | 1.49614624 |
| 149 | Mucosal telangiectasiae (HP:0100579) | 1.46049383 |
| 150 | Polyphagia (HP:0002591) | 1.45531995 |
| 151 | Thrombophlebitis (HP:0004418) | 1.43940079 |
| 152 | Arthropathy (HP:0003040) | 1.43564411 |
| 153 | Testicular neoplasm (HP:0010788) | 1.40542193 |
| 154 | Cerebral ischemia (HP:0002637) | 1.36067698 |
| 155 | Bladder neoplasm (HP:0009725) | 1.35285154 |
| 156 | Bladder carcinoma (HP:0002862) | 1.35285154 |
| 157 | Hypertriglyceridemia (HP:0002155) | 1.33924269 |
| 158 | Granulocytopenia (HP:0001913) | 1.33261300 |
| 159 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 1.32520077 |
| 160 | Pulmonary embolism (HP:0002204) | 1.32089467 |
| 161 | Mitral stenosis (HP:0001718) | 1.31862084 |
| 162 | Arthralgia (HP:0002829) | 1.30587101 |
| 163 | Infertility (HP:0000789) | 1.29407362 |
| 164 | Eosinophilia (HP:0001880) | 1.28381636 |
| 165 | Lower limb amyotrophy (HP:0007210) | 1.28142176 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 4.91357053 |
| 2 | MST4 | 4.60182682 |
| 3 | BMX | 4.25018876 |
| 4 | MAP4K1 | 3.94254012 |
| 5 | MYLK | 3.61409299 |
| 6 | MAP3K6 | 3.30816040 |
| 7 | TIE1 | 3.21558075 |
| 8 | MAP2K3 | 3.18239106 |
| 9 | EIF2AK1 | 3.16000762 |
| 10 | TXK | 3.09155278 |
| 11 | BLK | 3.01077972 |
| 12 | NME2 | 2.83520299 |
| 13 | TBK1 | 2.53342794 |
| 14 | KIT | 2.42002240 |
| 15 | SIK3 | 2.37959436 |
| 16 | SYK | 2.27415130 |
| 17 | ZAP70 | 2.21615279 |
| 18 | GRK6 | 2.18011792 |
| 19 | GRK5 | 2.13930468 |
| 20 | BTK | 2.12432780 |
| 21 | JAK3 | 2.02179940 |
| 22 | IKBKE | 2.01545008 |
| 23 | FGR | 1.94233742 |
| 24 | TEC | 1.88343223 |
| 25 | BMPR2 | 1.86636722 |
| 26 | MAP3K14 | 1.67498881 |
| 27 | MATK | 1.62364928 |
| 28 | KDR | 1.61637145 |
| 29 | CSF1R | 1.50982860 |
| 30 | LYN | 1.48495735 |
| 31 | SIK2 | 1.48377950 |
| 32 | IKBKB | 1.46982036 |
| 33 | TNK2 | 1.46911960 |
| 34 | SIK1 | 1.41164038 |
| 35 | STK3 | 1.37756305 |
| 36 | PIM1 | 1.32106262 |
| 37 | TGFBR2 | 1.29197272 |
| 38 | MAPKAPK3 | 1.28952385 |
| 39 | CDC7 | 1.27690912 |
| 40 | PAK1 | 1.21542650 |
| 41 | CCNB1 | 1.19112615 |
| 42 | TGFBR1 | 1.16462772 |
| 43 | YES1 | 1.16275955 |
| 44 | LMTK2 | 1.07266913 |
| 45 | DAPK3 | 1.06704358 |
| 46 | LCK | 1.05215143 |
| 47 | CDK19 | 1.05023206 |
| 48 | MAP3K5 | 1.04938490 |
| 49 | FES | 1.04929156 |
| 50 | PLK2 | 1.01924384 |
| 51 | ACVR1B | 1.00192535 |
| 52 | HCK | 0.98692190 |
| 53 | MAP2K6 | 0.98595951 |
| 54 | STK10 | 0.98211291 |
| 55 | MARK3 | 0.97379254 |
| 56 | RPS6KA4 | 0.94797826 |
| 57 | MKNK1 | 0.94073033 |
| 58 | ITK | 0.94000224 |
| 59 | PTK2B | 0.91634390 |
| 60 | IRAK4 | 0.89168105 |
| 61 | TRIB3 | 0.88252539 |
| 62 | IRAK1 | 0.87947717 |
| 63 | TAOK1 | 0.87935867 |
| 64 | TAOK2 | 0.87469531 |
| 65 | EPHA3 | 0.86461058 |
| 66 | PIK3CG | 0.85752828 |
| 67 | ERN1 | 0.85523084 |
| 68 | WEE1 | 0.83788849 |
| 69 | CLK1 | 0.83731321 |
| 70 | RPS6KB2 | 0.82817581 |
| 71 | TYK2 | 0.81755617 |
| 72 | PASK | 0.81379610 |
| 73 | TNIK | 0.80187144 |
| 74 | DAPK2 | 0.78817388 |
| 75 | ADRBK1 | 0.78677672 |
| 76 | NEK2 | 0.77496244 |
| 77 | PDK1 | 0.77322537 |
| 78 | RIPK1 | 0.77227536 |
| 79 | MAP3K12 | 0.76836703 |
| 80 | DYRK3 | 0.76655857 |
| 81 | ARAF | 0.75114641 |
| 82 | LRRK2 | 0.74679447 |
| 83 | PNCK | 0.73308894 |
| 84 | ERBB2 | 0.72652584 |
| 85 | JAK2 | 0.71983446 |
| 86 | TESK2 | 0.69764535 |
| 87 | CDK6 | 0.68768791 |
| 88 | MAPK12 | 0.68008686 |
| 89 | PRKD1 | 0.67629207 |
| 90 | MAPKAPK5 | 0.67115765 |
| 91 | PIM2 | 0.66821710 |
| 92 | HIPK2 | 0.66000257 |
| 93 | EPHB1 | 0.59939708 |
| 94 | CHUK | 0.59894535 |
| 95 | CDK8 | 0.59816376 |
| 96 | DYRK1B | 0.59368273 |
| 97 | TLK1 | 0.58281437 |
| 98 | TRIM28 | 0.57359903 |
| 99 | PKN1 | 0.57313765 |
| 100 | FER | 0.57259126 |
| 101 | EPHB2 | 0.55289059 |
| 102 | VRK1 | 0.55212445 |
| 103 | ADRBK2 | 0.54724224 |
| 104 | MAP3K11 | 0.54149001 |
| 105 | FYN | 0.53718424 |
| 106 | PDGFRB | 0.53487340 |
| 107 | MAP2K7 | 0.51848543 |
| 108 | STK16 | 0.50896898 |
| 109 | TAOK3 | 0.50561710 |
| 110 | PKN2 | 0.49705383 |
| 111 | PRKACG | 0.49042873 |
| 112 | MAP3K3 | 0.48855034 |
| 113 | STK24 | 0.48506359 |
| 114 | SCYL2 | 0.48066745 |
| 115 | CAMKK2 | 0.47169834 |
| 116 | EEF2K | 0.46384964 |
| 117 | MAP2K1 | 0.43856057 |
| 118 | MUSK | 0.43435632 |
| 119 | BCKDK | 0.43077942 |
| 120 | CSK | 0.43064399 |
| 121 | ILK | 0.42001883 |
| 122 | FLT3 | 0.41689519 |
| 123 | CDK7 | 0.40174928 |
| 124 | JAK1 | 0.39343795 |
| 125 | MAPK11 | 0.39022818 |
| 126 | PAK4 | 0.38002580 |
| 127 | PDPK1 | 0.37232236 |
| 128 | DAPK1 | 0.36792680 |
| 129 | MAP3K13 | 0.36749120 |
| 130 | PINK1 | 0.36150305 |
| 131 | MINK1 | 0.35652413 |
| 132 | MAPK4 | 0.35562663 |
| 133 | PRKCQ | 0.35423987 |
| 134 | ABL1 | 0.35159721 |
| 135 | IRAK2 | 0.34531264 |
| 136 | PRKG1 | 0.34510355 |
| 137 | CAMK1 | 0.33751406 |
| 138 | AURKB | 0.33218535 |
| 139 | PRKCD | 0.33218328 |
| 140 | RET | 0.32621843 |
| 141 | PAK3 | 0.32176629 |
| 142 | BMPR1B | 0.31577758 |
| 143 | NUAK1 | 0.31053386 |
| 144 | STK4 | 0.30323404 |
| 145 | PRKG2 | 0.29932723 |
| 146 | MAPK13 | 0.29791169 |
| 147 | IRAK3 | 0.29725547 |
| 148 | ABL2 | 0.29323110 |
| 149 | MAP3K1 | 0.29155785 |
| 150 | PLK1 | 0.28399523 |
| 151 | PRKCB | 0.28146920 |
| 152 | NLK | 0.26901521 |
| 153 | SRC | 0.25501010 |
| 154 | PRKCA | 0.24074295 |
| 155 | ROCK1 | 0.23724114 |
| 156 | SGK2 | 0.22837222 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Platelet activation_Homo sapiens_hsa04611 | 3.65585886 |
| 2 | DNA replication_Homo sapiens_hsa03030 | 3.59260572 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.34999914 |
| 4 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 3.22811060 |
| 5 | Ribosome_Homo sapiens_hsa03010 | 3.21002006 |
| 6 | Homologous recombination_Homo sapiens_hsa03440 | 2.81402225 |
| 7 | Mismatch repair_Homo sapiens_hsa03430 | 2.56044152 |
| 8 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.16199502 |
| 9 | Leishmaniasis_Homo sapiens_hsa05140 | 2.11058512 |
| 10 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.08003876 |
| 11 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.02389888 |
| 12 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.01925229 |
| 13 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.90802362 |
| 14 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.90260871 |
| 15 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.78727299 |
| 16 | Gap junction_Homo sapiens_hsa04540 | 1.75836139 |
| 17 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.70714355 |
| 18 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.68750853 |
| 19 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.57834410 |
| 20 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.56684248 |
| 21 | Measles_Homo sapiens_hsa05162 | 1.53881664 |
| 22 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.53071244 |
| 23 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.53069140 |
| 24 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.52042710 |
| 25 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.51875603 |
| 26 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.50668647 |
| 27 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.49562005 |
| 28 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.48809504 |
| 29 | Pertussis_Homo sapiens_hsa05133 | 1.46261473 |
| 30 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.45380529 |
| 31 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.41795147 |
| 32 | Endocytosis_Homo sapiens_hsa04144 | 1.37419171 |
| 33 | Base excision repair_Homo sapiens_hsa03410 | 1.32344142 |
| 34 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.29748793 |
| 35 | Legionellosis_Homo sapiens_hsa05134 | 1.29411839 |
| 36 | Malaria_Homo sapiens_hsa05144 | 1.27505584 |
| 37 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.24348050 |
| 38 | Alcoholism_Homo sapiens_hsa05034 | 1.24165566 |
| 39 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.21802445 |
| 40 | Other glycan degradation_Homo sapiens_hsa00511 | 1.21254250 |
| 41 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.20558231 |
| 42 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.18660958 |
| 43 | Galactose metabolism_Homo sapiens_hsa00052 | 1.18166595 |
| 44 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.17747310 |
| 45 | Phagosome_Homo sapiens_hsa04145 | 1.17220212 |
| 46 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.16975248 |
| 47 | Apoptosis_Homo sapiens_hsa04210 | 1.16967089 |
| 48 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.16477784 |
| 49 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.16090970 |
| 50 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.13707291 |
| 51 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.13532083 |
| 52 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.11254353 |
| 53 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.11099153 |
| 54 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.10490218 |
| 55 | Shigellosis_Homo sapiens_hsa05131 | 1.07724585 |
| 56 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.07649085 |
| 57 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.07043772 |
| 58 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.06035928 |
| 59 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.05858973 |
| 60 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.05110480 |
| 61 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.04412684 |
| 62 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.03539173 |
| 63 | Cell cycle_Homo sapiens_hsa04110 | 0.97954541 |
| 64 | Long-term depression_Homo sapiens_hsa04730 | 0.95124549 |
| 65 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.93329112 |
| 66 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.92786470 |
| 67 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.92574278 |
| 68 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.91972011 |
| 69 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.91416258 |
| 70 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.90200139 |
| 71 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.89560372 |
| 72 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.87993131 |
| 73 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.84762108 |
| 74 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.83494702 |
| 75 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.81010516 |
| 76 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.80124148 |
| 77 | Hepatitis B_Homo sapiens_hsa05161 | 0.80056416 |
| 78 | Allograft rejection_Homo sapiens_hsa05330 | 0.79897648 |
| 79 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.79230843 |
| 80 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.79204276 |
| 81 | Morphine addiction_Homo sapiens_hsa05032 | 0.78800598 |
| 82 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.78777252 |
| 83 | Olfactory transduction_Homo sapiens_hsa04740 | 0.77810429 |
| 84 | Tuberculosis_Homo sapiens_hsa05152 | 0.76041036 |
| 85 | Circadian entrainment_Homo sapiens_hsa04713 | 0.75374021 |
| 86 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.75006064 |
| 87 | ABC transporters_Homo sapiens_hsa02010 | 0.74348431 |
| 88 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.74003581 |
| 89 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.73632388 |
| 90 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.73191534 |
| 91 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.72970991 |
| 92 | Influenza A_Homo sapiens_hsa05164 | 0.72650882 |
| 93 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.71720993 |
| 94 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.70963271 |
| 95 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.70925997 |
| 96 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.70041294 |
| 97 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.69999329 |
| 98 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.69512524 |
| 99 | RNA degradation_Homo sapiens_hsa03018 | 0.69361703 |
| 100 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.68701711 |
| 101 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.67194273 |
| 102 | Spliceosome_Homo sapiens_hsa03040 | 0.66524326 |
| 103 | Endometrial cancer_Homo sapiens_hsa05213 | 0.62400044 |
| 104 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.62190896 |
| 105 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.61798609 |
| 106 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.61651391 |
| 107 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.59884220 |
| 108 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.59807650 |
| 109 | Purine metabolism_Homo sapiens_hsa00230 | 0.58788711 |
| 110 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.58548809 |
| 111 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.56723730 |
| 112 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.56259120 |
| 113 | Amoebiasis_Homo sapiens_hsa05146 | 0.54240953 |
| 114 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.51544148 |
| 115 | RNA polymerase_Homo sapiens_hsa03020 | 0.50568635 |
| 116 | Viral myocarditis_Homo sapiens_hsa05416 | 0.50274135 |
| 117 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.49813735 |
| 118 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.49805295 |
| 119 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.48701312 |
| 120 | Salmonella infection_Homo sapiens_hsa05132 | 0.47360967 |
| 121 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.46558770 |
| 122 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.45710218 |
| 123 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.45386687 |
| 124 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.44894006 |
| 125 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.44726661 |
| 126 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.44591296 |
| 127 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.44420321 |
| 128 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.44364589 |
| 129 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.44141052 |
| 130 | GABAergic synapse_Homo sapiens_hsa04727 | 0.44029734 |
| 131 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.43899276 |
| 132 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.42789426 |
| 133 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.41889671 |
| 134 | Renin secretion_Homo sapiens_hsa04924 | 0.41572809 |
| 135 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.40982041 |
| 136 | Glioma_Homo sapiens_hsa05214 | 0.40165329 |
| 137 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.37690073 |
| 138 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.37525642 |
| 139 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.37523961 |
| 140 | Proteasome_Homo sapiens_hsa03050 | 0.37391248 |
| 141 | HTLV-I infection_Homo sapiens_hsa05166 | 0.37106537 |
| 142 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.37094118 |
| 143 | Asthma_Homo sapiens_hsa05310 | 0.36434603 |
| 144 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.32896485 |
| 145 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.32439790 |
| 146 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.32368566 |
| 147 | Hepatitis C_Homo sapiens_hsa05160 | 0.30947784 |
| 148 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.28933761 |
| 149 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.26850846 |
| 150 | Focal adhesion_Homo sapiens_hsa04510 | 0.25586115 |
| 151 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.23921980 |

